Evidence map›Paper›PMID 32962139›Full record

ArticleBiomedicines2020

Dibenzoylthiamine Has Powerful Antioxidant and Anti-Inflammatory Properties in Cultured Cells and in Mouse Models of Stress and Neurodegeneration.

Margaux Sambon, Anna Gorlova, Alice Demelenne, Judit Alhama-Riba, Bernard Coumans, Bernard Lakaye, Pierre Wins, Marianne Fillet, Daniel C Anthony, Tatyana Strekalova and 1 more

Open access · goldAbstract read
In one paragraph

Article in Biomedicines, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.2field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Beneficial Effects of Putative Hydrogen Sulfide (HMolecules (Basel, Switzerland) · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 5 countries.

Margaux SambonLaboratory of Neurophysiology, GIGA-Neurosciences, University of Liège, 4000 Liège, Belgium.
Anna GorlovaDepartment of Psychiatry and Neuropsychology, Maastricht University, 6200 MD Maastricht, The Netherlands.
Alice DemelenneLaboratory for the Analysis of Medicines, CIRM, Department of Pharmacy, University of Liège, 4000 Liège, Belgium.ORCID 0000-0002-0153-3621
Judit Alhama-RibaLaboratory of Neurophysiology, GIGA-Neurosciences, University of Liège, 4000 Liège, Belgium.ORCID 0000-0002-6917-0716
Bernard CoumansLaboratory of Molecular Regulation of Neurogenesis, GIGA-Stem Cell, University of Liège, 4000 Liège, Belgium.
Bernard LakayeLaboratory of Molecular Regulation of Neurogenesis, GIGA-Stem Cell, University of Liège, 4000 Liège, Belgium.
Pierre WinsLaboratory of Neurophysiology, GIGA-Neurosciences, University of Liège, 4000 Liège, Belgium.
Marianne FilletLaboratory for the Analysis of Medicines, CIRM, Department of Pharmacy, University of Liège, 4000 Liège, Belgium.
Daniel C AnthonyInstitute of Molecular Medicine Laboratory of Psychiatric Neurobiology and Department of Normal Physiology, Sechenov First Moscow State Medical University, 119991 Moscow, Russia.ORCID 0000-0003-1380-6655
Tatyana StrekalovaDepartment of Psychiatry and Neuropsychology, Maastricht University, 6200 MD Maastricht, The Netherlands.
Lucien BettendorffLaboratory of Neurophysiology, GIGA-Neurosciences, University of Liège, 4000 Liège, Belgium.ORCID 0000-0002-2826-6789
University of Liège · BESechenov University · RU

Funding

"5-100" Russian Research Excellence program No grant numberFonds Leon Fredericq To Margaux Sambon (no grant number)Funds for Scientific Research - FNRS Lucien Bettendorff
6 · The paper itself

Abstract

Thiamine precursors, the most studied being benfotiamine (BFT), have protective effects in mouse models of neurodegenerative diseases. BFT decreased oxidative stress and inflammation, two major characteristics of neurodegenerative diseases, in a neuroblastoma cell line (Neuro2a) and an immortalized brain microglial cell line (BV2). Here, we tested the potential antioxidant and anti-inflammatory effects of the hitherto unexplored derivative O,S-dibenzoylthiamine (DBT) in these two cell lines. We show that DBT protects Neuro2a cells against paraquat (PQ) toxicity by counteracting oxidative stress at low concentrations and increases the synthesis of reduced glutathione and NADPH in a Nrf2-independent manner. In BV2 cells activated by lipopolysaccharides (LPS), DBT significantly decreased inflammation by suppressing translocation of NF-κB to the nucleus. Our results also demonstrate the superiority of DBT over thiamine and other thiamine precursors, including BFT, in all of the in vitro models. Finally, we show that the chronic administration of DBT arrested motor dysfunction in FUS transgenic mice, a model of amyotrophic lateral sclerosis, and it reduced depressive-like behavior in a mouse model of ultrasound-induced stress in which it normalized oxidative stress marker levels in the brain. Together, our data suggest that DBT may have therapeutic potential for brain pathology associated with oxidative stress and inflammation by novel, coenzyme-independent mechanisms.

Indexed as

amyotrophic lateral sclerosisanimal modelbenfotiamineinflammationlipopolysaccharideneurodegenerationoxidative stressparaquatstresssulbutiaminethiamine

Identifiers

PMID32962139
PMCPMC7555733
OpenAlexW3087483320

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.